Short- and long-term mortality in severe sepsis/septic shock in a setting with low antibiotic resistance: A prospective observational study in a Swedish University Hospital

Frontiers in Public Health

Volumn 1, Issue NOV, 2013, Pages

  Linnér, Anna ^a   Sundén Cullberg, Jonas ^a   Johansson, Linda ^a   Hjelmqvist, Hans ^a   Norrby Teglund, Anna ^a   Treutiger, Carl Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibiotics; Gender; Mortality; Septic shock; Severe sepsis

Indexed keywords

EID: 85009376699     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2013.00051     Document Type: Article

References (39)

1. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med (2003) 168:165-72. doi:10.1164/rccm.2201087
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 348:1546-54. doi:10.1056/NEJMoa022139
3. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospital-ization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med (2007) 35:1244-50. doi:10.1097/01.CCM. 0000261890.41311.E9
4. Esteban A, Frutos-Vivar F, Ferguson ND, Penuelas O, Lorente JA, Gordo F, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med (2007) 35:1284-9. doi:10.1097/01.CCM.0000260960. 94300.DE
5. Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ (2007) 335:879-83. doi:10.1136/bmj.39346.495880.AE
6. Warren BL, EidA,Singer P,Pillay SS, Carl P,NovakI,et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA (2001) 286:1869-78. doi:10.1001/jama.286.15.1869
7. Dellinger RP. Cardiovascular management of septic shock.Crit Care Med (2003) 31:946-55. doi:10.1097/01.CCM.0000057403.73299.A6
8. Laterre PF, Levy H, Clermont G, Ball DE, Garg R, Nelson DR, et al. Hospital mortality and resource use in subgroups of the recombinant human activated proteinCworldwide evaluation insevere sepsis (PROWESS) trial.Crit Care Med (2004) 32:2207-18.
9. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al. Brazilian sepsis epidemiological study (BASES study). Crit Care (2004) 8:R251-60. doi:10.1186/cc2892
10. Sprung CL,Annane D,Keh D,MorenoR,Singer M,Freivogel K,et al. Hydrocor-tisone therapy for patients with septic shock. N Engl J Med (2008) 358:111-24. doi:10.1056/NEJMoa071366
11. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 32:858-73. doi:10.1097/01.CCM.0000117317. 18092.E4
12. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2008) 34:17-60. doi:10.1007/ s00134-008-1040-9
13. Dellinger RP,LevyMM,RhodesA,Annane D,Gerlach H,Opal SM,et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 39:165-228. doi:10.1007/ s00134-012-2769-8
14. Townsend SR, Schorr C, Levy MM, Dellinger RP. Reducing mortality in severe sepsis: the surviving sepsis campaign. Clin Chest Med (2008) 29:721-33. doi:10.1016/j.ccm.2008.06.011
15. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 345:1368-77. doi:10.1056/NEJMoa010307
16. Jones AE, Brown MD, Trzeciak S, Shapiro NI, Garrett JS, Heffner AC, et al. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med (2008) 36:2734-9. doi:10.1097/CCM. 0b013e318186f839
17. Gaieski DF,Mikkelsen ME,BandRA,PinesJM,MassoneR,FuriaFF,et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med (2010) 38:1045-53. doi:10.1097/CCM.0b013e3181cc4824
18. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Dura-tion of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med (2006) 34:1589-96. doi:10.1097/01.CCM.0000217961.75225.E9
19. Puskarich MA, Trzeciak S,Shapiro NI,Arnold RC, Horton JM, Studnek JR,et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med (2011) 39:2066-71. doi:10.1097/CCM.0b013e31821e87ab
20. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Out-comes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis (2012) 12:919-24. doi:10.1016/S1473-3099(12)70239-6
21. Karlsson S, Varpula M, Ruokonen E, Pettila V, Parviainen I, Ala-Kokko TI, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med (2007) 33:435-43. doi:10.1007/s00134-006-0504-z
22. Varpula M, Karlsson S, Parviainen I, Ruokonen E, Pettila V. Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand (2007) 51:1320-6. doi:10.1111/j.1399-6576. 2007.01439.x
23. Flaatten H. Epidemiology of sepsis in Norway in 1999. Crit Care (2004) 8:R180-4. doi:10.1186/cc2867
24. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med (2005) 33:564-73. doi:10.1097/01.CCM.0000155991.88802.4D
25. Sunden-Cullberg J,Nystrom T,Lee ML, Mullins GE, Tokics L,Andersson J, et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med (2007) 35:1536-42. doi:10.1097/01.CCM. 0000266536.14736.03
26. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 101:1644-55. doi:10.1378/chest.101.6.1644
27. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med (1985) 13:818-29. doi:10.1097/ 00003246-198510000-00009
28. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 22:707-10. doi:10.1007/BF01709751
29. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med (2012) 366:2055-64. doi:10.1056/NEJMoa1202290
30. Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotictherapyon survival.Chest (2003) 123:1615-24. doi:10.1378/ chest.123.5.1615
31. Guidet B, Aegerter P, Gauzit R, Meshaka P, Dreyfuss D. Incidence and impact of organ dysfunctions associated with sepsis. Chest (2005) 127:942-51. doi:10. 1378/chest.127.3.942
32. Volakli E, Spies C, Michalopoulos A, Groeneveld AB, Sakr Y, Vincent JL. Infections of respiratory or abdominal origin in ICU patients: what are the differences? Crit Care (2010) 14:R32. doi:10.1186/cc8909
33. Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med (2010) 38:1036-43. doi:10.1097/CCM.0b013e3181d455b6
34. Puskarich MA, Marchick MR, Kline JA, Steuerwald MT, Jones AE. One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Crit Care (2009) 13:R167. doi:10.1186/cc8138
35. Hanberger H, Erlandsson M, Burman LG, Cars O, Gill H, Lindgren S, et al. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scand J Infect Dis (2004) 36:24-30. doi:10.1080/ 00365540310017429
36. Molstad S,Cars O,StruweJ. Strama-a Swedish working model for containment of antibiotic resistance. Euro Surveill (2008) 13:ii:19041.
37. Adrie C, Azoulay E, Francais A, Clec'h C, Darques L, Schwebel C, et al. Influence of gender on the outcome of severe sepsis: a reappraisal. Chest (2007) 132:1786-93. doi:10.1378/chest.07-0420
38. Pietropaoli AP, Glance LG, Oakes D, Fisher SG. Gender differences in mortality in patients with severe sepsis or septic shock. Gend Med (2010) 7:422-37. doi:10.1016/j.genm
39. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med (2006) 34:2576-82. doi:10.1097/01.CCM.0000239114. 50519.0E